Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03292406
Title A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (CTCL)
Acronym CTCL
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Galderma R&D
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | DEU

Facility Status City State Zip Country Details
Galderma Investigational Site Orange California 92868 United States Details
Galderma Investigational Site Palo Alto California 94304 United States Details
Galderma Investigational Site Farmington Connecticut 06032 United States Details
Galderma Investigational Site Chicago Illinois 60611 United States Details
Galderma Investigational Site Boston Massachusetts 02115 United States Details
Galderma Investigational Site Durham North Carolina 27710 United States Details
Galderma Investigational Site Philadelphia Pennsylvania 19104 United States Details
Galderma Investigational Site Philadelphia Pennsylvania 19107 United States Details
Galderma Investigational Site Pittsburgh Pennsylvania 15213 United States Details
Galderma Investigational Site Dallas Texas 75231 United States Details
Galderma Investigational Site Houston Texas 77030 United States Details
Galderma Investigational Site Pierre-Bénite Auvergne-Rhône-Alpes 69310 France Details
Galderma Investigational Site Nantes Pays De La Loire 44093 France Details
Galderma Investigational Site Paris Île-de-France 75010 France Details
Galderma Investigational Site Mannheim Baden-Württemberg 68167 Germany Details
Galderma Investigational Site Wurzburg Bavaria 97080 Germany Details
Galderma Investigational Site Krefeld North Rhine-Westphalia 47805 Germany Details
Galderma Investigational Site Minden North Rhine-Westphalia 32429 Germany Details
Galderma Investigational Site Münster North Rhine-Westphalia 48149 Germany Details
Galderma Investigational Site Kiel Schleswig-Holstein 24105 Germany Details
Galderma Investigational Site Berlin 10117 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field